Heyholder
‹ Activism Filings

GemVax & KAEL Co.,Ltd. Q3 operating loss of KRW 1.9 billion, turning to a loss; revenue KRW 23.4 billion

GemVax & KAEL Co.,Ltd.· Periodic Report

AI summary · Not investment advice

Gemvax sold KRW 23.4 billion in Q3 but lost KRW 1.9 billion from its main business, turning from profit to loss versus a year earlier.

Operating profit · 3 months

KRW -1.9 billion

Key facts

Revenue (3 months)
KRW 23.4 billion
Net income (3 months)
KRW -8.6 billion
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 18.0 billion
Revenue (year to date)
KRW 64.4 billion
Operating profit (prior-year 3 months)
KRW 722.8 million
Operating profit (year to date)
KRW -1.7 billion
Net income (prior-year 3 months)
KRW -2.5 billion
Net income (year to date)
KRW -20.0 billion

Commentary

AI commentary · Not investment advice

What happened

Gemvax reported its consolidated results for the 3rd quarter of 2026 in its quarterly report. Sales for the latest 3 months were KRW 23.4 billion, up 30.2% from KRW 18.0 billion in the same period a year earlier. Cumulative sales this year are KRW 64.4 billion.

In the company's terms

Operating profit (profit from the core business) for the latest 3 months was a loss of KRW 1.9 billion. A year earlier, the same period showed a profit of KRW 0.7 billion, so it turned into a loss. Cumulative operating profit this year is a loss of KRW 1.7 billion.

What changes for shareholders

Net income (the final profit after taxes and all other items) for the latest 3 months was a loss of KRW 8.6 billion. A year earlier it was a loss of KRW 2.5 billion. Cumulative net income this year is a loss of KRW 20.0 billion.

Comments

No comments yet

Comments from shareholders will appear here.